Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)
Condition(s):MyelofibrosisLast Updated:October 31, 2023Completed
Hide Studies Not Open or Pending
Condition(s):MyelofibrosisLast Updated:October 31, 2023Completed
Condition(s):MyelofibrosisLast Updated:July 12, 2022Withdrawn
Condition(s):MyelofibrosisLast Updated:May 6, 2023Active, not recruiting
Condition(s):Myelofibrosis (MF)Last Updated:March 3, 2023Active, not recruiting
Condition(s):MyelofibrosisLast Updated:February 7, 2024Completed
Condition(s):Primary Myelofibrosis; Primary Pulmonary Hypertension; Secondary Myelofibrosis; Pulmonary Arterial HypertensionLast Updated:March 21, 2016Terminated
Condition(s):MyelofibrosisLast Updated:August 7, 2012Completed
Condition(s):MyelofibrosisLast Updated:February 13, 2024Active, not recruiting
Condition(s):MyelofibrosisLast Updated:February 29, 2024Recruiting
Condition(s):Primary MyelofibrosisLast Updated:May 5, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.